Diabetic retinopathy: Medical management and assessment

Hospital Medicine

Volumn 64, Issue 7, 2003, Pages 400-403

  Delli Castelli, M ^a   Leslie, R D G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

BLOOD PRESSURE; CLINICAL FEATURE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; MEDICAL ASSESSMENT; PREGNANCY; REDUCTION; RISK FACTOR; FEMALE; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY DIABETES MELLITUS; REVIEW;

BLOOD PRESSURE; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; EXERCISE; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 0042887433     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2003.64.7.2276     Document Type: Conference Paper

References (12)

1. American Diabetes Association (2002) Diabetic retinopathy. Diabetes Care 25(suppl 1): S90-93
2. Chaturvedi N, Sjolie AK, Stephenson JM et al (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351: 28-31
3. Diabetes Control and Complications Trial (DCCT) Research Group (1993) The effect of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-86
4. Diabetes Control and Complications Trial (DCCT) Research Group (2000) Effect of pregnancy on microvascular complications in the DCCT. Diabetes Care 23: 1084-91
5. Estacio RO, Jeffers BW, Gifford N, Schrier RW (2000) Effect of blood pressure control on diabetic microvascular complications in patients with hypertensiom and type 2 diabetes. Diabetes Care 23(Suppl 2): B54-B64
6. Klein R (1995) Hyperglycaemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18: 258-71
7. Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105: 1801-15
8. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321: 405-12
9. UK Prospective Diabetes Study Group (1998a) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-53
10. UK Prospective Diabetes Study Group (1998b) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group. Br Med J 317: 703-13
11. Van Leiden HA, Dekker JM, Moll A et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy. Diabetes Care 25(8): 1320-5
12. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) study investigators. N Engl J Med 342: 145-53